Division of Hematology and Oncology, Department of Internal Medicine, Southern Illinois University School of Medicine and SimmonsCooper Cancer Institute at SIU, Springfield, IL 62794-9678, USA.
Int J Cancer. 2010 Jun 15;126(12):2799-812. doi: 10.1002/ijc.24900.
Rab proteins are a group of ubiquitously expressed proteins that are responsible for intracellular transport of vesicles. Recent evidence has shown that certain Rab proteins are involved in the pathogenesis of cancer. We have recently shown that Rab25 is lost in a large fraction of breast cancer samples, particularly those derived from hormonally insensitive tumors. We have further investigated the role of Rab25 by re-expressing Rab25 in tumorigenic cell lines and measuring the impact on tumor formation as well as on various molecular pathways through PCR array analysis. In vivo tumor growth of cell lines with re-expressed Rab25 was markedly suppressed. Our data suggest that Rab25 acts through multiple pathways to enhance apoptosis and to suppress angiogenesis and invasion by modulating VEGF-A and VEGFR-1 expression. These findings suggest that Rab25 represents a novel class of cellular modulators that can influence both tumor initiation and the progression of the established tumors, thus ultimately affecting the biology of the malignant disease.
Rab 蛋白是一组广泛表达的蛋白,负责囊泡的细胞内运输。最近的证据表明,某些 Rab 蛋白参与了癌症的发病机制。我们最近表明,Rab25 在很大一部分乳腺癌样本中丢失,特别是那些来自激素不敏感肿瘤的样本。我们通过在致瘤细胞系中重新表达 Rab25 并通过 PCR 阵列分析测量对肿瘤形成以及各种分子途径的影响进一步研究了 Rab25 的作用。具有重新表达的 Rab25 的细胞系的体内肿瘤生长明显受到抑制。我们的数据表明,Rab25 通过多种途径发挥作用,通过调节 VEGF-A 和 VEGFR-1 的表达来增强细胞凋亡并抑制血管生成和侵袭。这些发现表明,Rab25 代表了一类新的细胞调节剂,它可以影响肿瘤的起始和已建立肿瘤的进展,从而最终影响恶性疾病的生物学特性。